FDA Import Refusal SCS-1786956-6/12/1 — AFSANA AKTER
The FDA refused shipment SCS-1786956-6/12/1 from AFSANA AKTER (Bangladesh) on Jul 21, 2025. The refused product falls under Drugs and Biologics — UPADACITINIB (ANTI-RHEUMATIC). Cited charges: 118,75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Jul 21, 2025
- Country
- Bangladesh
- Product Category
- Drugs and Biologics
- Product Code
- 62QDA06 UPADACITINIB (ANTI-RHEUMATIC)
- Charges
- 118,75